<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Res Pharm Pract</journal-id><journal-id journal-id-type="iso-abbrev">J Res Pharm Pract</journal-id><journal-id journal-id-type="publisher-id">JRPP</journal-id><journal-title-group><journal-title>Journal of Research in Pharmacy Practice</journal-title></journal-title-group><issn pub-type="ppub">2319-9644</issn><issn pub-type="epub">2279-042X</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25984545</article-id><article-id pub-id-type="pmc">4418140</article-id><article-id pub-id-type="publisher-id">JRPP-4-79</article-id><article-id pub-id-type="doi">10.4103/2279-042X.154365</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Different doses of intravenous Magnesium sulfate on cardiovascular changes following the laryngoscopy and tracheal intubation: A double-blind randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Honarmand</surname><given-names>Azim</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Safavi</surname><given-names>Mohammadreza</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Badiei</surname><given-names>Sajad</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Daftari-Fard</surname><given-names>Neda</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</aff><author-notes><corresp id="cor1"><bold>Corresponding author:</bold> Prof. Mohammadreza Safavi, E-mail: <email xlink:href="safavi@med.mui.ac.ir">safavi@med.mui.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2015</year></pub-date><volume>4</volume><issue>2</issue><fpage>79</fpage><lpage>84</lpage><history><date date-type="received"><month>1</month><year>2015</year></date><date date-type="accepted"><month>2</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Journal of Research in Pharmacy Practice</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objective:</title><p>Laryngoscopy and intratracheal intubation may cause acute hemodynamic instabilities due to catecholamine release. Magnesium sulfate (MgSO<sub>4</sub>) prevents catecholamine release and results in bradycardia and vasodilatation, so can be used to diminish complications of laryngoscopy and intubation in doses &#x0003e; 50 mg/kg. The aim of this study was to compare the different doses of MgSO<sub>4</sub> used to improve cardiovascular instabilities due to laryngoscopy and intratracheal intubation.</p></sec><sec id="st2"><title>Methods:</title><p>In this double-blind randomized controlled trial, 120 patients undergoing elective surgery were divided equally into four groups (<italic>n</italic> = 30) and received different doses of MgSO<sub>4</sub> as case groups (Group I: 30 mg/kg, Group II: 40 mg/kg, Group III: 50 mg/kg) or the equal volume of normal saline as a control group. The patients&#x02019; hemodynamic status was recorded at baseline, before laryngoscopy and in 1, 3, 5, and 10 minutes after laryngoscopy. Bradycardia, tachycardia, hypertension, hypotension, ST-T changes, arrhythmias, and duration of extubation and laryngoscopy were also recorded.</p></sec><sec id="st3"><title>Findings:</title><p>There was no significant difference in heart rate between four groups (P<sub>baseline</sub> = 0.46, P<sub>preoperation</sub> = 0.55, P<sub>1 min</sub> = 0.86, P<sub>3 min</sub> = 0.30, P<sub>5 min</sub> = 0.63, P<sub>10 min</sub> = 0.74). Systolic, diastolic and mean arterial pressures were statistically significant less at 1, 3, and 5 minutes after intubation in comparison with other times of following-up in the three groups received MgSO<sub>4</sub> than the control group.</p></sec><sec id="st4"><title>Conclusion:</title><p>The use of MgSO<sub>4</sub> in doses less than 50 mg/kg can be effective to reduce cardiovascular instability related to laryngoscopy and tracheal intubation.</p></sec></abstract><kwd-group><kwd>Intra-tracheal</kwd><kwd>intubation</kwd><kwd>laryngoscopy</kwd><kwd>Magnesium sulfate</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Laryngoscopy and tracheal intubation cause catecholamine release due to the sympathoadrenal stimulation. This effect can cause acute hemodynamic instabilities such as increasing in blood pressure, heart rate (HR), pulmonary artery, and capillary wedge pressure.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Hemodynamic instability is defined as a state which requires for circulatory or mechanical support to maintain a normal blood pressure or cardiac output. The changes in hemodynamic parameters &#x0003e;20% of basal value for each patient is usually considered as abnormal.[<xref rid="ref1" ref-type="bibr">1</xref>] These complications cause significant adverse effects especially in patients with heart diseases and pulmonary disorders.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref>]</p><p>Various pharmacological agents have been used to prevent these effects consisting adrenoreceptor blockers,[<xref rid="ref7" ref-type="bibr">7</xref>] narcotics,[<xref rid="ref8" ref-type="bibr">8</xref>] calcium channel blockers,[<xref rid="ref9" ref-type="bibr">9</xref>] sodium channel blockers,[<xref rid="ref10" ref-type="bibr">10</xref>] vasodilators,[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref>] and paracetamol.[<xref rid="ref14" ref-type="bibr">14</xref>]</p><p>Magnesium sulfate (MgSO<sub>4</sub>) inhibits catecholamine release from adrenal glands.[<xref rid="ref15" ref-type="bibr">15</xref>] It was shown that MgSO<sub>4</sub> reduces levels of serum epinephrine and cause a decrease in the atrial contraction, bradycardia, and vasodilatation.[<xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref>] Puri <italic>et al</italic>.[<xref rid="ref18" ref-type="bibr">18</xref>] showed that MgSO<sub>4</sub> 50 mg/kg administered before laryngoscopy could attenuated the pressor response to tracheal intubation better than lidocaine. However, the effects of the other doses of magnesium on the hemodynamic responses to laryngoscopy were not investigated before. We designed the present study to compare the effects of different doses of MgSO<sub>4</sub> on suppression of cardiovascular responses to the laryngoscopy and endotracheal intubation.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>After obtaining institutional approval from the Ethic Committee of Isfahan University of Medical Sciences (Isfahan, Iran), this double-blinded randomized controlled study was performed from September 2012 to July 2013.</p><p>We obtained written informed consent from 120 patients aged 18&#x02013;65 years with America Society of Anesthesiologists physical status grades I&#x02013;II, who underwent elective surgery under general anesthesia with endotracheal intubation.</p><p>Patients were not included in our study if they had previous history of renal disease, cardiovascular, gastrointestinal or neurological disorders, use of anticoagulant drugs, calcium channel blockers, known allergies to the study drug, and airway malformation. No pregnant patient was included into the study. Furthermore, if there was any change in technique of anesthesia or duration of laryngoscopy for &#x0003e;30 s, the patient was excluded from the study.</p><p>After arriving to the operating room, patients were randomly allocated to one of the four groups (30 patients in each group). Randomization was performed using simple block method. Patients in Groups I, II, and III received intravenous (IV) MgSO<sub>4</sub> (30 mg/kg, 40 mg/kg and 50 mg/kg, respectively) over 1 min, while in control group, they received only the equal volume of IV saline 0.09% (Group S). General anesthesia was induced with IV propofol (2 mg/kg), IV fentanyl (3 &#x003bc;g/kg), and atracurium 0.6 mg/kg for facilitation of muscle relaxation. Tracheal intubation was performed after 2 min from injection of atracurium. Anesthesia was continued with 1.25% isoflurane in combination with 50% oxygen in nitric oxide. Morphine 0.1 mg/kg was used for intraoperative analgesia. Ventilation of the lungs was adjusted to maintain an end-tidal CO<sub>2</sub> of 35-40 mmHg. After surgery, IV neostigmine 0.04 mg/kg and atropine 0.02 mg/kg were used to reverse muscle relaxation. The serum level of MgSO<sub>4</sub> was not measured at any time throughout the study.</p><p>Anesthesia was performed by an anesthetist who was not involved in data collection. HR, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP) and arterial oxygen saturation were recorded noninvasively before induction of anesthesia, just before laryngoscopy, and at 1, 3, 5, and 10 min after endotracheal intubation.</p><p>Grade of laryngoscopy was recorded by the use of Cromak&#x02013;Lehane classification:[<xref rid="ref19" ref-type="bibr">19</xref>] In Grade I, most of the glottic opening can be seen. In Grade II, only the posterior portion of the glottis or only arytenoid cartilages is visible. In Grade III, only the epiglottis but no portion of the glottis is visible and in Grade IV, neither the glottis nor the epiglottis can be seen.</p><p>Duration of laryngoscopy, extubation time, hypotension (SBP &#x0003c;20% of basal), hyper-tension (SBP &#x0003e;20% of basal), tachy-cardia (increased HR &#x0003e;20% of baseline), arrhythmias and changes in ST-T segments (&#x0003e;10 mm depression relative to baseline) were also recorded. Recordation of data was performed by a nurse who was unaware of the study group allocation.</p><p>For sample size estimation, we used MedCalc 9.0 statistical software and determined a sample population of 30 patients in each group needed to ensure 80% statistical power at &#x003b1; =0.05 to detect the 25% difference in MAP at maximum pressor response after intubation, with 0.3 difference in standard deviation (SD). Data are presented as mean &#x000b1; SD or numbers (percentages). One-way analysis of variance and <italic>post hoc</italic> comparisons at various points in time using Bonferroni's type I error rate correction was used to compare differences in mean values between groups. Chi-square test was used for analysis of qualitative variables. The <italic>P</italic> &#x0003c; 0.05 was considered statistically significant. Statistical analyses were performed with SPSS 20.0 for Windows (SPSS Inc., Chicago, IL, USA).</p></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>Totally, 120 patients were recruited to the study. No participant excluded from the study. No statistically significant difference was found in demographic characteristics between four groups [<xref ref-type="table" rid="T1">Table 1</xref>]. There was no significant difference in grading of laryngoscopy and duration of laryngoscopy among four groups [<xref ref-type="table" rid="T1">Table 1</xref>]. Furthermore, there was no statistically significant difference in HR values in different time intervals among four groups [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic characteristic, grading and duration of laryngoscopy, and extubation time of the study patients in four groups</p></caption><graphic xlink:href="JRPP-4-79-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>HR changes in different time intervals in four study groups</p></caption><graphic xlink:href="JRPP-4-79-g002"/></table-wrap><p>The mean SBP, DBP, and MAP at 1, 3, and 5 min after laryngoscopy was significantly less in Group I, Group II, and Group III compared with Group S. These variables were not statistically significant at 10 min after laryngoscopy compared with the control group. Furthermore, there was no significant difference among Group I, Group II, and Group III with respect to these variables [Tables <xref ref-type="table" rid="T3">3</xref>&#x02013;<xref ref-type="table" rid="T5">5</xref>]. As shown in <xref ref-type="table" rid="T3">Table 3</xref>, the percentage of patients with SBP changes &#x0003c;20% of basal value to percentage of patients with SBP changes &#x0003e;20% of basal value in Group III was significantly more than Group S (<italic>P</italic> &#x0003c; 0.05).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>SBP changes in different time intervals in four study groups</p></caption><graphic xlink:href="JRPP-4-79-g003"/></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>DBP changes in different time intervals in four study groups</p></caption><graphic xlink:href="JRPP-4-79-g004"/></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>MAP changes in different time intervals in four study groups</p></caption><graphic xlink:href="JRPP-4-79-g005"/></table-wrap><p>There was no significant difference in extubation time between four groups [<xref ref-type="table" rid="T1">Table 1</xref>]. The incidence of hypertension, hypotension, tachycardia, bradycardia, and arrhythmias was not significantly different among the four groups [<xref ref-type="table" rid="T6">Table 6</xref>].</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>The incidence of cardiovascular complications in four study groups</p></caption><graphic xlink:href="JRPP-4-79-g006"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>To the best of our knowledge, the present study is the first one investigated the effect of administering MgSO<sub>4</sub> with doses of &#x0003c;50 mg/kg (30 mg/kg and 40 mg/kg) for prevention of cardiovascular changes after laryngoscopy in normotensive patients.</p><p>Our results showed that using lower doses of MgSO<sub>4</sub> (30 mg/kg or 40 mg/kg, IV) comparable with using 50 mg/kg IV could significantly decrease the SBP, DBP, and MBP changes till 5 min after laryngoscopy in comparison with control group.</p><p>Calcium has a major role in the release of catecholamines from the adrenal medulla and adrenergic nerve terminals in response to the stimulation by sympathetic nervous system. Magnesium competes with calcium for binding to the membrane channels. Hence, magnesium acts as a calcium antagonist and can modify the responses that mediated by calcium. Hence, MgSO<sub>4</sub> blocks release of catecholamine stores and decrease responses to adrenergic stimulations.[<xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref>]</p><p>Laurant <italic>et al</italic>.[<xref rid="ref23" ref-type="bibr">23</xref>] showed that IV MgSO<sub>4</sub> attenuated the release both catecholamine and vasopressin in mesenteric resistance arteries of spontaneously hypertensive rats.[<xref rid="ref23" ref-type="bibr">23</xref>]</p><p>Magnesium sulfate is utilized in conditions with catecholamine excess such as tetanus,[<xref rid="ref24" ref-type="bibr">24</xref>] pheochromocytoma,[<xref rid="ref25" ref-type="bibr">25</xref>] and ST elevation anterior myocardial infarction.[<xref rid="ref26" ref-type="bibr">26</xref>] MgSO<sub>4</sub> also directly reduces smooth muscle tonicity and subsequently vascular contraction.[<xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref>] Therefore, MgSO<sub>4</sub> is useful to decrease systemic hypertension, as using for treatment of pregnancy induced hypertension.[<xref rid="ref29" ref-type="bibr">29</xref>]</p><p>Laryngoscopy and endotracheal intubation, two daily common procedures with catecholamine release, are usually performed for general anesthesia[<xref rid="ref11" ref-type="bibr">11</xref>] and cardiopulmonary resuscitation.[<xref rid="ref30" ref-type="bibr">30</xref>] In one study, the authors believed IV use of lidocaine 1.5 mg/kg or MgSO<sub>4</sub> 60 mg/kg before anesthetic induction reduced mean arterial and systolic pressures in the first 2 min after intubation better than lidocaine while the effect of these drugs on HR was not significantly different.[<xref rid="ref11" ref-type="bibr">11</xref>]</p><p>James <italic>et al</italic>.[<xref rid="ref15" ref-type="bibr">15</xref>] evaluated the effect of IV MgSO<sub>4</sub> on catecholamine release related to tracheal intubation. They compared IV MgSO<sub>4</sub> 60 mg/kg with an equal volume of IV 0.09% sodium chloride both IV over 1 min before laryngoscopy. They recorded plasma concentration of magnesium and catecholamine immediately before, during and after intubation, and also 2 and 5 min after intubation. They demonstrated induction of general anesthesia induced no significant changes in HR while it caused a decrease in SBP and DBP, arterial blood pressure.</p><p>In a similar randomized control trial study, Puri and Batra[<xref rid="ref31" ref-type="bibr">31</xref>] appraised the effect of IV MgSO<sub>4</sub> 50 mg/kg on hemodynamics changes after tracheal intubation in patients suffering coronary artery disease scheduled for coronary artery bypass graft. They used MgSO<sub>4</sub> for 19 sedated patients and normal saline 0.05 mL/kg for 17 patients. They showed MgSO<sub>4</sub> effectively prevented the rise in arterial blood pressure associated with endotracheal intubation. In addition, this drug could decrease ST segment changes during laryngoscopy.</p><p>In our study, magnesium attenuated the increase in blood pressure till 5 min after laryngoscopy. The ineffectiveness of magnesium administration for prevention of the rise in blood pressure 10 min after laryngoscopy was probably due to decrease in catecholamine release in this time. After laryngoscopy and tracheal intubation, the catecholamines rises maximally till 5 min and after that its release gradually decrease.[<xref rid="ref15" ref-type="bibr">15</xref>]</p><p>Stanbury[<xref rid="ref32" ref-type="bibr">32</xref>] showed that MgSO<sub>4</sub> prolongs sinus node recovery time by indirect and direct inhibition on the sinoatrial node. It was shown that magnesium slows HR at rest by blockade of the nictitating membrane of the sympathetic ganglia. Magnesium has a negative chronotropic effect after administration of atropine.[<xref rid="ref33" ref-type="bibr">33</xref>] It was probable that stress of laryngoscopy and consequently stimulation of sympathetic nervous system was so large that could not be attenuated by the parasympathetic effect of magnesium on the sinoatrial node at dosage used in our study. It is recommended that future studies with higher dosage of MgSO<sub>4</sub> designs to investigate this issue.</p><p>Magnesium caused vasodilation by sympathetic blockade and inhibition of catecholamine release. IV magnesium administration results in a decrease in systemic vascular resistance. Due to these effects, magnesium inhibited the increase in arterial pressure after laryngoscopy and tracheal intubation.[<xref rid="ref34" ref-type="bibr">34</xref>]</p><p>In our study, there were no significant ST segment changes during induction and tracheal intubation. This could be due to decrease in afterload and coronary vasodilation produced by magnesium administration.[<xref rid="ref35" ref-type="bibr">35</xref>] The effect of magnesium on the coronary and systemic arteries is probably due to its calcium antagonist effect.[<xref rid="ref36" ref-type="bibr">36</xref>]</p><p>We did not measure the plasma level of MgSO<sub>4</sub> during the study periods. This is a limitation of our study. We recommend future study in this issue with considering such limitation.</p><p>In conclusion, magnesium administered at dosages of 30 mg/kg, 40 mg/kg, and 50 mg/kg comparably attenuated the increase in arterial pressure changes after laryngoscopy and endotracheal intubation without significant effect on the HR changes.</p></sec><sec id="sec1-5"><title>AUTHORS&#x02019; CONTRIBUTION</title><p>MRS has planned the study and finalized it; SB, AH, ND and MRS did the statistical analysis and prepared the first version of manuscript for publish. All authors read and approved the final manuscript.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>The authors wish to sincerely thank the support of all the colleagues in Kashani Hospital Medical Center affiliated to Isfahan University of Medical Sciences in Isfahan, Iran. Furthermore, our special thanks go to the patients, who wholeheartedly and actively assisted us to carry out this research. No conflict of interest existed. This prospective randomized observational study was approved by the Ethics Committee of our university, (Isfahan University of Medical Sciences) and all patients gave written, informed consent.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> The authors wish to sincerely thank the support of all the colleagues in Kashani Hospital Medical Center affiliated to Isfahan University of Medical Sciences in Isfahan, Iran</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruder</surname><given-names>N</given-names></name><name><surname>Ortega</surname><given-names>D</given-names></name><name><surname>Granthil</surname><given-names>C</given-names></name></person-group><article-title>Consequences and prevention methods of hemodynamic changes during laryngoscopy and intratracheal intubation</article-title><source>Ann Fr Anesth Reanim</source><year>1992</year><volume>11</volume><fpage>57</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">1359816</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>SV</given-names></name><name><surname>Balaji</surname><given-names>D</given-names></name><name><surname>Ahmed</surname><given-names>SN</given-names></name></person-group><article-title>Dexmedetomidine versus esmolol to attenuate the hemodynamic response to laryngoscopy and tracheal intubation: A randomized double-blind clinical study</article-title><source>Int J Appl Basic Med Res</source><year>2014</year><volume>4</volume><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">25143884</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Tacon</surname><given-names>S</given-names></name><name><surname>Wolter</surname><given-names>P</given-names></name><name><surname>Rusterholtz</surname><given-names>T</given-names></name><name><surname>Harlay</surname><given-names>M</given-names></name><name><surname>Gayol</surname><given-names>S</given-names></name><name><surname>Sauder</surname><given-names>P</given-names></name><etal/></person-group><article-title>Complications of difficult tracheal intubations in a critical care unit</article-title><source>Ann Fr Anesth Reanim</source><year>2000</year><volume>19</volume><fpage>719</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">11200758</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stauffer</surname><given-names>JL</given-names></name><name><surname>Olson</surname><given-names>DE</given-names></name><name><surname>Petty</surname><given-names>TL</given-names></name></person-group><article-title>Complications and consequences of endotracheal intubation and tracheotomy. A prospective study of 150 critically ill adult patients</article-title><source>Am J Med</source><year>1981</year><volume>70</volume><fpage>65</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">7457492</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rashkin</surname><given-names>MC</given-names></name><name><surname>Davis</surname><given-names>T</given-names></name></person-group><article-title>Acute complications of endotracheal intubation. Relationship to reintubation, route, urgency, and duration</article-title><source>Chest</source><year>1986</year><volume>89</volume><fpage>165</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3943375</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natanson</surname><given-names>C</given-names></name><name><surname>Shelhamer</surname><given-names>JH</given-names></name><name><surname>Parrillo</surname><given-names>JE</given-names></name></person-group><article-title>Intubation of the trachea in the critical care setting</article-title><source>JAMA</source><year>1985</year><volume>253</volume><fpage>1160</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">3155810</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>S</given-names></name><name><surname>Seki</surname><given-names>S</given-names></name><name><surname>Hidaka</surname><given-names>K</given-names></name><name><surname>Masuoka</surname><given-names>M</given-names></name><name><surname>Tsuchida</surname><given-names>H</given-names></name></person-group><article-title>The hemodynamic effects of landiolol, an ultra-short-acting &#x003b2;1-selectiveblocker, on endotracheal intubationin patients with and without hypertension</article-title><source>Anesth Analg</source><year>2007</year><volume>104</volume><fpage>124</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17179256</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Berg</surname><given-names>AA</given-names></name><name><surname>Halliday</surname><given-names>EM</given-names></name><name><surname>Soomro</surname><given-names>NA</given-names></name><name><surname>Rasheed</surname><given-names>A</given-names></name><name><surname>Baloch</surname><given-names>M</given-names></name></person-group><article-title>Reducing cardiovascular responses to laryngoscopy and tracheal intubation: A comparison of equipotent doses of tramadol, nalbuphine and pethidine, with placebo</article-title><source>Middle East J Anaesthesiol</source><year>2004</year><volume>17</volume><fpage>1023</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">15651510</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>J</given-names></name><name><surname>Mitsuhata</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name><name><surname>Enzan</surname><given-names>K</given-names></name></person-group><article-title>Attenuation of cardiovascular response to laryngoscopy and tracheal intubation with bolus injection of diltiazem</article-title><source>Masui</source><year>1992</year><volume>41</volume><fpage>356</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">1560574</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takita</surname><given-names>K</given-names></name><name><surname>Morimoto</surname><given-names>Y</given-names></name><name><surname>Kemmotsu</surname><given-names>O</given-names></name></person-group><article-title>Tracheal lidocaine attenuates the cardiovascular response to endotracheal intubation</article-title><source>Can J Anaesth</source><year>2001</year><volume>48</volume><fpage>732</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11546711</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nooraei</surname><given-names>N</given-names></name><name><surname>Dehkordi</surname><given-names>ME</given-names></name><name><surname>Radpay</surname><given-names>B</given-names></name><name><surname>Teimoorian</surname><given-names>H</given-names></name><name><surname>Mohajerani</surname><given-names>SA</given-names></name></person-group><article-title>Effects of intravenous magnesium sulfate and lidocaine on hemodynamic variables following direct laryngoscopy and intubation in elective surgery patients</article-title><source>Tanaffos</source><year>2013</year><volume>12</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">25191450</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Berg</surname><given-names>AA</given-names></name><name><surname>Savva</surname><given-names>D</given-names></name><name><surname>Honjol</surname><given-names>NM</given-names></name></person-group><article-title>Attenuation of the haemodynamic responses to noxious stimuli in patients undergoing cataract surgery. A comparison of magnesium sulphate, esmolol, lignocaine, nitroglycerine and placebo given i.v. with induction of anaesthesia</article-title><source>Eur J Anaesthesiol</source><year>1997</year><volume>14</volume><fpage>134</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">9088811</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freye</surname><given-names>E</given-names></name><name><surname>Levy</surname><given-names>JV</given-names></name></person-group><article-title>Reflex activity caused by laryngoscopy and intubation is obtunded differently by meptazinol, nalbuphine and fentanyl</article-title><source>Eur J Anaesthesiol</source><year>2007</year><volume>24</volume><fpage>53</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16834791</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kord</surname><given-names>Valeshabad A</given-names></name><name><surname>Nabavian</surname><given-names>O</given-names></name><name><surname>Nourijelyani</surname><given-names>K</given-names></name><name><surname>Kord</surname><given-names>H</given-names></name><name><surname>Vafainejad</surname><given-names>H</given-names></name><name><surname>Kord</surname><given-names>Valeshabad R</given-names></name><etal/></person-group><article-title>Attenuation of Hemodynamic Responses to Laryngoscopy and Tracheal Intubation: Propacetamol versus Lidocaine-A Randomized Clinical Trial</article-title><source>Anesthesiol Res Pract 2014</source><year>2014</year><comment>170247</comment></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>MF</given-names></name><name><surname>Beer</surname><given-names>RE</given-names></name><name><surname>Esser</surname><given-names>JD</given-names></name></person-group><article-title>Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation</article-title><source>Anesth Analg</source><year>1989</year><volume>68</volume><fpage>772</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2735543</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambling</surname><given-names>DR</given-names></name><name><surname>Birmingham</surname><given-names>CL</given-names></name><name><surname>Jenkins</surname><given-names>LC</given-names></name></person-group><article-title>Magnesium and the anaesthetist</article-title><source>Can J Anaesth</source><year>1988</year><volume>35</volume><fpage>644</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">3060283</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikka</surname><given-names>H</given-names></name><name><surname>Toivonen</surname><given-names>L</given-names></name><name><surname>Pellinen</surname><given-names>T</given-names></name><name><surname>Verkkala</surname><given-names>K</given-names></name><name><surname>J&#x000e4;rvinen</surname><given-names>A</given-names></name><name><surname>Nieminen</surname><given-names>MS</given-names></name></person-group><article-title>The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation</article-title><source>Eur Heart J</source><year>1993</year><volume>14</volume><fpage>251</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8449202</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puri</surname><given-names>GD</given-names></name><name><surname>Marudhachalam</surname><given-names>KS</given-names></name><name><surname>Chari</surname><given-names>P</given-names></name><name><surname>Suri</surname><given-names>RK</given-names></name></person-group><article-title>The effect of magnesium sulphate on hemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease</article-title><source>Anesth Analg</source><year>1998</year><volume>87</volume><fpage>808</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">9768774</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattano</surname><given-names>D</given-names></name><name><surname>Schober</surname><given-names>P</given-names></name><name><surname>Krage</surname><given-names>R</given-names></name><name><surname>van Rijn</surname><given-names>C</given-names></name><name><surname>van Groeningen</surname><given-names>D</given-names></name><name><surname>Loer</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Cormack-Lehane classification revisited</article-title><source>Br J Anaesth</source><year>2010</year><volume>105</volume><fpage>698</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20952430</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>WW</given-names></name><name><surname>Rubin</surname><given-names>RP</given-names></name></person-group><article-title>The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus-secretion coupling</article-title><source>J Physiol</source><year>1963</year><volume>167</volume><fpage>288</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">16992152</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Euler</surname><given-names>US</given-names></name><name><surname>Lishajko</surname><given-names>F</given-names></name></person-group><article-title>Effects of Mg2+ and Ca2+ on noradrenaline release and uptake in adrenergic nerve granules in differential media</article-title><source>Acta Physiol Scand</source><year>1973</year><volume>89</volume><fpage>415</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">4767242</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>JH</given-names></name><name><surname>Chai</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Chae</surname><given-names>YK</given-names></name><name><surname>Choi</surname><given-names>SS</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><etal/></person-group><article-title>Attenuation of hemodynamic responses to laryngoscopy and tracheal intubation during rapid sequence induction: Remifentanil vs. lidocaine with esmolol</article-title><source>Minerva Anestesiol</source><year>2010</year><volume>76</volume><fpage>188</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">20203546</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurant</surname><given-names>P</given-names></name><name><surname>Touyz</surname><given-names>RM</given-names></name><name><surname>Schiffrin</surname><given-names>EL</given-names></name></person-group><article-title>Effect of magnesium on vascular tone and reactivity in pressurized mesenteric resistance arteries from spontaneously hypertensive rats</article-title><source>Can J Physiol Pharmacol</source><year>1997</year><volume>75</volume><fpage>293</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">9196855</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>MF</given-names></name><name><surname>Manson</surname><given-names>ED</given-names></name></person-group><article-title>The use of magnesium sulphate infusions in the management of very severe tetanus</article-title><source>Intensive Care Med</source><year>1985</year><volume>11</volume><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">3968303</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>MF</given-names></name></person-group><article-title>Magnesium sulfate in pheochromocytoma</article-title><source>Anesthesiology</source><year>1985</year><volume>62</volume><fpage>189</fpage><lpage>201</lpage></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>H</given-names></name><name><surname>Katayama</surname><given-names>T</given-names></name><name><surname>Honda</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Yano</surname><given-names>K</given-names></name></person-group><article-title>Cardioprotective effects of magnesium sulfate in patients undergoing primary coronary angioplasty for acute myocardial infarction</article-title><source>Circ J</source><year>2004</year><volume>68</volume><fpage>23</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14695461</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turlapaty</surname><given-names>PD</given-names></name><name><surname>Altura</surname><given-names>BM</given-names></name></person-group><article-title>Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle</article-title><source>Eur J Pharmacol</source><year>1978</year><volume>52</volume><fpage>421</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">729651</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altura</surname><given-names>BM</given-names></name><name><surname>Altura</surname><given-names>BT</given-names></name></person-group><article-title>Magnesium and vascular tone and reactivity</article-title><source>Blood Vessels</source><year>1978</year><volume>15</volume><fpage>5</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">630136</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>ZQ</given-names></name><name><surname>Huo</surname><given-names>YQ</given-names></name><name><surname>Yao</surname><given-names>LJ</given-names></name><name><surname>Wei</surname><given-names>XG</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name></person-group><article-title>Change of hs-CRP, sVCAM-1, NT-proBNP levels in patients with pregnancy-induced hypertension after therapy with magnesium sulfate and nifedipine</article-title><source>Asian Pac J Trop Med</source><year>2013</year><volume>6</volume><fpage>897</fpage><lpage>901</lpage><pub-id pub-id-type="pmid">24083587</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandelwal</surname><given-names>N</given-names></name><name><surname>Galgon</surname><given-names>RE</given-names></name><name><surname>Ali</surname><given-names>M</given-names></name><name><surname>Joffe</surname><given-names>AM</given-names></name></person-group><article-title>Cardiac arrest is a predictor of difficult tracheal intubation independent of operator experience in hospitalized patients</article-title><source>BMC Anesthesiol</source><year>2014</year><volume>14</volume><fpage>38</fpage><pub-id pub-id-type="pmid">24904233</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puri</surname><given-names>GD</given-names></name><name><surname>Batra</surname><given-names>YK</given-names></name></person-group><article-title>Effect of nifedipine on cardiovascular responses to laryngoscopy and intubation</article-title><source>Br J Anaesth</source><year>1988</year><volume>60</volume><fpage>579</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">3377933</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanbury</surname><given-names>JB</given-names></name></person-group><article-title>The blocking action of magnesium ion on sympathetic ganglia</article-title><source>J Pharmacol Exp Ther</source><year>1948</year><volume>93</volume><fpage>52</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">18865186</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somjen</surname><given-names>GG</given-names></name><name><surname>Baskerville</surname><given-names>EN</given-names></name></person-group><article-title>Effect of excess magnesium on vagal inhibition and acetylcholine sensitivity of the mammalian heart <italic>in situ</italic> and <italic>in vitro</italic>
</article-title><source>Nature</source><year>1968</year><volume>217</volume><fpage>679</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">5637751</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidov</surname><given-names>M</given-names></name><name><surname>Gavrilovich</surname><given-names>L</given-names></name><name><surname>Mroczek</surname><given-names>W</given-names></name><name><surname>Finnerty</surname><given-names>FA</given-names><suffix>Jr</suffix></name></person-group><article-title>Relation of extracellular fluid volume to arterial pressure during drug-induced saluresis</article-title><source>Circulation</source><year>1969</year><volume>40</volume><fpage>349</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">5810891</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Critelli</surname><given-names>G</given-names></name><name><surname>Ferro</surname><given-names>G</given-names></name><name><surname>Peschle</surname><given-names>C</given-names></name><name><surname>Perticone</surname><given-names>Fr</given-names></name><name><surname>Rengo</surname><given-names>Fr</given-names></name><name><surname>Condorelli</surname><given-names>M</given-names></name></person-group><article-title>Myocardial contractility after injection of prolonged infusion of magnesium sulphate</article-title><source>Acta Cardiol</source><year>1977</year><volume>32</volume><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">300967</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turlapaty</surname><given-names>PD</given-names></name><name><surname>Altura</surname><given-names>BM</given-names></name></person-group><article-title>Magnesium deficiency produces spasms of coronary arteries: Relationship to etiology of sudden death ischemic heart disease</article-title><source>Science</source><year>1980</year><volume>208</volume><fpage>198</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">7361117</pub-id></element-citation></ref></ref-list></back></article>